Keyphrases
Acute Respiratory Distress Syndrome
75%
Antiviral Drugs
25%
Balb C Mice
25%
Changes in Gene Expression
25%
Coagulopathic
100%
Coagulopathy
25%
Complement Membrane Attack Complex
25%
COVID-19
100%
COVID-19 Severity
25%
Defense Strategy
25%
Drug Antibodies
25%
Heart Inflammation
25%
High Mortality
25%
Highly Effective
25%
Immune Regulation
25%
Immuno
100%
Immunomodulatory
25%
Improved Outcomes
25%
Inflammatory Lung Disease
25%
Long COVID
50%
Lung
25%
Lung Inflammation
50%
M1 Macrophages
25%
Monoclonal Antibody
25%
Mouse Infection
100%
Mouse-adapted SARS-CoV-2
25%
Myxoma Virus
25%
PEGylated
25%
Plasminogen
25%
Protease
75%
SARS-CoV-2 Model
25%
Self-defense
25%
Sequential Change
25%
Serine Protease Inhibitor
25%
SERP1
75%
Serpin
100%
Soluble Urokinase Plasminogen Activator Receptor (suPAR)
50%
Systemic Treatment
25%
Therapeutic Potential
25%
Thrombotic
75%
Vasculitis
25%
Viral
100%
Pharmacology, Toxicology and Pharmaceutical Science
Adult Respiratory Distress Syndrome
75%
Anti-Inflammatory Drug
100%
Antivirus Agent
25%
Bagg Albino Mouse
25%
Blood Clotting Disorder
25%
Carditis
25%
Complement Inhibitor
25%
Complement Membrane Attack Complex
25%
Drug Antibody
25%
Fibrinolytic Agent
25%
Immunoglobulin
100%
Infection
100%
Monoclonal Antibody
25%
Mouse
25%
Mouse Model
100%
Myxoma Virus
25%
Plasminogen Activator Inhibitor
25%
Pneumonia
75%
Proteinase
75%
Pulmonary Vasculitis
25%
SARS Coronavirus
100%
Serine Proteinase Inhibitor
100%
Syndrome
25%
Systemic Treatment
25%
Urokinase Receptor
50%
Immunology and Microbiology
Bagg Albino Mouse
25%
Complement Membrane Attack Complex
25%
COVID-19
25%
Drug Antibody
25%
Gene Expression
25%
Intravenous Immunoglobulin
100%
Macrophage
25%
Monoclonal Antibody
25%
Mouse
25%
Mouse Model
100%
Myxoma Virus
25%
Postcovid Syndrome
50%
Pulmonary Inflammation
25%
Serpin
100%
Severe Acute Respiratory Syndrome Coronavirus 2
100%
Urokinase Receptor
50%
Vasculitis
25%